Clinical Trials Insight: 700030263
Phase of Trial: Phase I
Latest Information Update: 28 Sep 2010
At a glance
- Drugs AFP 464 (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors Kirax Corporation
- 28 Sep 2010 Status changed from recruiting to completed according to a Tigris Pharmaceuticals media release.
- 01 Feb 2008 New trial record.
- 30 Jan 2008 The first patient was dosed in December and enrolment is ongoing; reported in a Tigris media release.